BioCentury | Aug 5, 2020
Management Tracks
CureVac makes Haas’ CEO job permanent; plus Zhang now CEO of Legend and updates from Royalty, NBE, Black Diamond, VelosBio and more
...same position at Ra Pharmaceuticals Inc., which UCB S.A. acquired for $2.3 billion last year. Sierra Oncology Inc....
...Pharma plc NBE-Therapeutics AG Black Diamond Therapeutics Inc. VelosBio Inc. Aspen Neuroscience Inc. Humanigen Inc. Engrail Therapeutics Inc. MiMedx Group Inc. Rhythm Pharmaceuticals Inc. Sierra Oncology Inc. Legend...
...Pharma plc NBE-Therapeutics AG Black Diamond Therapeutics Inc. VelosBio Inc. Aspen Neuroscience Inc. Humanigen Inc. Engrail Therapeutics Inc. MiMedx Group Inc. Rhythm Pharmaceuticals Inc. Sierra Oncology Inc. Legend...